Overview
Austria packaging producer's Q1 sales fell 11% yr/yr, mainly due to TANN sale
Pro forma Q1 sales down 5.9%, adjusted EBITDA nearly flat, operating profit up 5.6%
Company cites cost pressures from geopolitical risks, mitigated by Fit-For-Future programme
Outlook
Company expects subdued demand and intense competition to persist throughout 2026
Company sees increased cost pressure from geopolitical tensions, especially in energy and chemicals
Mayr-Melnhof Karton says Fit-For-Future programme is progressing faster than planned
Result Drivers
COST PRESSURE - Co said significant cost pressures, especially from energy, transportation and chemicals due to Middle East tensions, negatively impacted results
COST REDUCTIONS - Operational progress and cost discipline under Fit-For-Future programme helped mitigate market and cost challenges
PHARMA & HEALTHCARE PACKAGING - Earnings growth in Pharma & Healthcare Packaging division supported group operating profit
Company press release: ID:nEQ3hGHlda
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
EUR 927.50 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the paper packaging peer group is "buy"
Wall Street's median 12-month price target for Mayr-Melnhof Karton AG is €95.50, about 12% above its April 27 closing price of €85.30
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 14 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)